Subject: PSID Announces Powerful Co-Marketing Agreement

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement., Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
Facebook Twitter YouTube
PSID Announces Powerful Co-Marketing Agreement
Hot Stock to WatchHot Stock to Watch

Company: PositiveID Corporation (OTCQB: PSID)

End of Day:

Price: 0.0167

Change (%): + 0.0005 (3.09)

Volume: 736,460
PSID Chart

PositiveID and DirectView Security Systems Enter Into Co-Marketing Agreement to Jointly Market Products to Homeland Security and First Responders

Companies to cross market PositiveID's biological detection and diagnostic solutions with DirectView's video surveillance and body worn camera technologies

DELRAY BEACH, Florida, June 10, 2015 /PRNewswire/ - PositiveID Corporation (“PositiveID” or “Company”) (OTCQB: PSID), a developer of biological detection and diagnostics solutions, announced today that it has entered a co-marketing agreement with DirectView Security Systems, Inc. (“DirectView”) (OTC: DIRV), a provider of video surveillance systems including body worn cameras, to jointly market the companies’ products to homeland security and first responders.

PositiveID develops molecular diagnostic systems, including Firefly Dx, which is designed to provide real-time, accurate diagnostic results in a handheld device, thereby leading to treatment scenarios at the point of need that are not possible with existing systems, which require lab-based equipment and can take hours or even days to provide results. Firefly’s applications for first responders include point-of-need, lab-quality detection of pathogenic organisms and detection of biological agents associated with weapons of mass destruction.

Continue Reading

Top PerformerYesterday's Top Performer

Company: World Oil Group, Inc. (Pink Sheets: WOGI)

End of Day:

Price: 0.0052

Change (%): + 0.0011 (26.83)

Volume: 517,679
WOGI Chart

A New Audio Interview With Nathan Hall, CEO of World Oil Group, Inc., is Now at

AUSTIN, Texas, June 9, 2015 (GLOBE NEWSWIRE) --, Inc. (SCV) and World Oil Group, Inc. (OTC:WOGI) announced today that a new audio interview with Nyxio World Oil Group, Inc. ("WOGI" or the "Company"), is now available. The interview can be heard at

WOGI's CEO, Nathan Hall, Inc. called into to provide the listening audience with a comprehensive overview of the Company's history, the highlights from the amazing year for the Company in 2014, as well as his own candid insights into the goals for the Company in 2015.

Continue Reading

Other Small Cap News

Company: New Generation Consumer Group (Pink Sheets: NGCG)

New Generation Consumer Group Announces New Product and Agreement With UFC Hall of Famer

WHITTIER, CA--(Marketwired - Jun 10, 2015) - New Generation Consumer Group (OTC PINK: NGCG) - New Generation Consumer Group Inc. announces a signed agreement with the godfather of mixed martial arts, Ken Shamrock. Ken Shamrock is recognized worldwide as a fierce MMA fighter, and is an inductee into the UFC Hall of Fame. Mr. Shamrock has also wrestled in the WWF and was the first ever Pancrase Heavyweight World Champion in Japan. Ken Shamrock is also the founder of the Lion's Den, a renowned fighting school where some of the world's best fighters have trained.

New Generation Consumer Group also announces Top Dogg Testosterone Booster. Top Dogg Testosterone Booster Power & Performance Formula is an all-natural Testosterone Booster that contains scientifically researched key ingredients that are proven to boost free testosterone levels promoting the growth of lean muscle mass, strength, stamina, power, and overall male vitality. Top Dogg works naturally with the body with no harmful side effects, and no worrying about cycling on and off of the product.

Continue Reading

Company: iHookup Social, Inc. (Pink Sheets: HKUP)

iHookup Social Grows International Successes as New App/Brand Launch of "friendable" Draws Near

Company Also Successfully Concludes Debt Consolidation Transactions, Kicking Off the Next Growth Phase

CAMPBELL, CA--(Marketwired - Jun 10, 2015) - iHookup Social, Inc. (Pink Sheets: HKUP), a fully reporting public company that develops and markets a mobile/social app positioned at the intersection of social media and location based connections, is pleased to announce that the Company has completed an eight week effort to consolidate various notes controlled by third party debt holders. The Company believes these consolidations better position the company for its next phase of growth.

iHookup Social's App also continues to post significant results in international app markets, achieving many of its best rankings to date in recent months. Along with its reduction in the number of debt holders the Company believes it can now achieve an increased valuation for the company's business. The Company greatly values the aforementioned as it turns its focus toward the release of its "friendable" brand to the Apple App Store in July of 2015.

Continue Reading

Company: Regen BioPharma, Inc. (OTCBB: RGBP)

Cancer Clinical Trials Expert Dr. Santosh Kesari to Assist Regen BioPharma, Inc. in Addressing FDA Questions Regarding Planned dCellVax Immunotherapy Clinical Trial for Breast Cancer

SAN DIEGO, Calif., June 10, 2015 /PRNewswire/ -- Regen BioPharma, Inc. (OTCBB: RGBP) announced today the initiation of a collaboration with Dr. Santosh Kesari , Professor and Director of Neuro-oncology at University of California San Diego . The goals of the collaboration is to address questions posed by the FDA regarding Regn BioPharma, Inc.'s planned Phase I/II clinical trial assessing safety with signals of efficacy of the dCellVax gene silenced dendritic cell immunotherapy for treating breast cancer and to modify the existing Investigational New Drug application in order to maximize the probability of clinical trial success . The proposed trial will recruit 10 patients with metastatic breast cancer and will involve 4 monthly injections of the dCellVax gene-silenced dendritic cell therapy. The trial will last one year, with tumor assessment before therapy and at 6 and 12 months.

"Using the immune system to treat cancer offers great potential in that the immune system destroys tumor cells, but then establishes immunological memory, which constantly patrols the body for rogue cells." Said Dr. Kesari, "Having served as a member of Regen's Scientific Advisory Board, I am excited to be involved in this collaboration, in which we aim to help expediently address the questions posed by the FDA and allow for clinical entry of dCellVax."

Continue Reading

Company: Omega World Inc. (Pink Sheets: OMWDF)

Omega World Inc., Announces Joint Venture with Airless Bike Korea Ltd.

NEW YORK--(BUSINESS WIRE)--Omega World Inc.(OMWDF), a publicly traded company on the OTC Pink Sheets, has entered into a joint venture agreement with Airless Bike Korea Ltd.

The joint venture will have the worldwide distribution rights to the patented airless tube and puncture free tires for the commercial and pleasure markets produced by Airless Bike Korea Ltd.

Continue Reading

Market News

By Fred Imbert: CNBC

Cramer: Retail's too hit-or-miss right now

CNBC's Jim Cramer says investors may want to steer clear of retail stocks.

"Nothing is working the way it's supposed to in retail," Cramer said on "Squawk on the Street." "What happened to Kohl's? They were the hottest thing in the world and then they just disappeared. Wal-Mart [hit] a 52-week low yesterday. ... This group is very hard to [play]."

On the other hand, there are retailers such as Target that are outperforming following corporate concerns, Cramer added. "This was a company that we were worried about its credit rating not that long ago, and this company's [risen] very quickly."

Continue Reading

By Lawrence Lewitinn:

Global markets present a warning for the US: Trader

Market corrections in Europe and Asia have traders worrying the U.S. could be next.

The Bombay Sensex and the German DAX are now 11 percent below their respective late-January and mid-April highs. Meanwhile the S&P 500 is down 2 percent from its record highs set last month.

That has some investment managers warning traders to tread with caution.

"It's definitely flashing yellow all across the world," said Boris Schlossberg, managing director at BK Asset Management. "At the very minimum, investors should take some protection, maybe in terms of buying puts."

Continue Reading

Like Us on FacebookFollow Us on Twitter

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks